Your session is about to expire
← Back to Search
Diagnostic Test
Swab for Flu-Related Pain (INSPIRE Trial)
N/A
Recruiting
Led By Song Yu
Research Sponsored by LumiraDx UK Limited
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 4 months
Awards & highlights
No Placebo-Only Group
Summary
This trial looked at how well the LumiraDx test works for Influenza A/B and RSV at various point of care testing sites.
Eligible Conditions
- Flu-Related Pain
- Flu
- Respiratory Syncytial Virus Infection
- Respiratory Syncytial Virus
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 4 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~4 months
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Performance evaluation by health care professionals
Performance evaluation by non-laboratory users
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Group I: Nasopharyngeal swabExperimental Treatment1 Intervention
Nasopharyngeal swab from subjects with signs and symptoms of influenza and/or RSV-like illness
Group II: Nasal swabExperimental Treatment1 Intervention
Nasal swab from subjects with signs and symptoms of influenza and/or RSV-like illness
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Swab
2019
N/A
~100
Find a Location
Who is running the clinical trial?
LumiraDx UK LimitedLead Sponsor
15 Previous Clinical Trials
32,490 Total Patients Enrolled
Song YuPrincipal InvestigatorMedHelp Urgent Care
Michael BellPrincipal InvestigatorAccel-West Volusia Pediatrics
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:Research Study Groups:
This trial has the following groups:- Group 1: Nasopharyngeal swab
- Group 2: Nasal swab
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger